PneumaCare Announces Appointment of Seasoned Industry Veteran Mark Harwood as New Chief Executive Oficer
Mark Harwood is a highly experienced individual with an outstanding commercial track record in the medical device industry. He was previously President and CEO of ArjoHuntleigh in Roselle, US and subsequent to that Vice President of Baxter International Inc. (Global) based in Chicago, IL, US. He then moved on to become President of RF Technologies (North America & EMEA) based in Brookfield WI, US. He has also gained extensive experience outside of the US, as Managing Director for Arjo Med AB, UK & Ireland.
Mark is a native Oxonian but has strong roots in East Anglia where he now resides. He has wide-ranging experience in medical device technology with an outstanding commercial track record and is a strong team builder. Mark also has extensive regulatory and quality experience, which is very relevant to PneumaCare as they are finalising their FDA 510k approval in the US.
"I am very excited to join PneumaCare", said Mark Harwood, new CEO of the Cambridge-based medical imaging company. "PneumaCare represents the very best in innovation for medical imaging and I am looking forward to working with the team, increasing revenue and brand awareness in core markets, providing our Customers and stakeholders an attractive return on investment and to build long term business relationships with them".
Dr. Bill Mason, Chairman of PneumaCare, commented, "We are very fortunate to have identified Mark Harwood as the new Chief Executive Officer of PneumaCare. He has an engineering and marketing background. This includes wide experience of both growing small companies in the medical device space, as well as managing large teams of several hundred people involved in commercial, manufacturing and regulatory aspects of the businesses with which he has been involved. His experience includes critical and long-term hospital care as well as special needs patients. He has a strong global track record in Europe and North America. He arrives at PneumaCare at a critical time in its development and our Board believes he will play a pivotal role in taking the Company to the next stage of its development and beyond."
- End -
About PneumaCare
PneumaCare is a Cambridge (UK)-based medical imaging company providing clinicians with innovative respiratory diagnostic and monitoring equipment using novel 3D-imaging technology. Its first two products, Thora-3DI™ and PneumaScan™, are CE mark approved and are already being used in and sold to clinics, pre- and post-operative assessments, drug testing, and device development by both public and private health care providers. Further applications of PneumaCare’s proprietary Structured Light Plethysmography technology, developed in close partnership with the clinical community, include neonatal, critical care, and rehabilitation applications. PneumaCare's technology allows clinicians to make detailed non-invasive measurements of respiratory physiology parameters which are critical as diagnostic tools for the physician.
PneumaCare was founded in 2009 to address directly the needs of respiratory clinicians.
510(k) Approval Pending
For more information please contact:
Dr. Bill Mason
Chairman
PneumaCare Limited
St John’s Innovation Centre
Cowley Road
Cambridge CB4 0WS
United Kingdom
Tel: +44 (0) 1223 703 151
Mob: +44 7785 950134
www.pneumacare.com mailto:[email protected] Twitter: @Pneumacare